Published in Circulation on January 22, 2002
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart (2006) 4.94
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ (2016) 2.81
Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ (2010) 2.53
Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial. Br J Gen Pract (2010) 2.42
Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation study. PLoS One (2008) 2.37
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med (2003) 2.22
Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet (2009) 2.04
Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study. Heart (2010) 1.91
Premature coronary artery disease in Indians and its associated risk factors. Vasc Health Risk Manag (2005) 1.76
Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories. Eur J Epidemiol (2012) 1.75
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Can non-physician health-care workers assess and manage cardiovascular risk in primary care? Bull World Health Organ (2007) 1.67
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia (2009) 1.65
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis? Clin Res Cardiol (2007) 1.56
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). Circulation (2016) 1.43
Family physician-led, team-based, lifestyle intervention in patients with metabolic syndrome: results of a multicentre feasibility project. CMAJ Open (2017) 1.40
Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One (2010) 1.34
Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies. Eur Heart J (2012) 1.30
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet (2006) 1.29
Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol (2006) 1.29
Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol (2008) 1.24
Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation (2008) 1.24
Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health (2013) 1.23
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis (2004) 1.21
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Cardiovascular risk scores do not account for the effect of treatment: a review. Heart (2011) 1.19
Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation (2011) 1.19
The Framingham Heart Study's impact on global risk assessment. Prog Cardiovasc Dis (2010) 1.16
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract (2008) 1.16
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2008) 1.14
Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS). BMC Public Health (2008) 1.13
Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning. Br J Cancer (2004) 1.12
Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol (2007) 1.11
A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population. PLoS One (2011) 1.11
Isoprenoid metabolism and the pleiotropic effects of statins. Curr Atheroscler Rep (2003) 1.11
Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med (2012) 1.10
Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol (2010) 1.09
Cardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population. BMC Med (2010) 1.08
Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results). BMJ Open (2011) 1.07
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol (2008) 1.06
Is whole-body FDG-PET valuable for health screening? Against. Eur J Nucl Med Mol Imaging (2005) 1.05
Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Fail (2009) 1.04
Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nat Rev Cardiol (2011) 1.04
Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS One (2012) 1.03
Global risk of cardiovascular disease. Heart (2003) 1.02
Non-invasive screening for coronary artery disease: calcium scoring. Heart (2007) 1.01
Classical and novel biomarkers for cardiovascular risk prediction in the United States. J Epidemiol (2013) 1.00
The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med (2015) 0.98
Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart (2013) 0.98
Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography. J Cardiovasc Magn Reson (2009) 0.97
Red blood cell fatty acid patterns and acute coronary syndrome. PLoS One (2009) 0.97
The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet (2006) 0.96
Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK). Scand J Prim Health Care (2007) 0.96
The independent relationship between triglycerides and coronary heart disease. Vasc Health Risk Manag (2009) 0.95
Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.94
Clinical prediction rules in practice: review of clinical guidelines and survey of GPs. Br J Gen Pract (2014) 0.94
The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis (2010) 0.94
Comparison of current guidelines for primary prevention of coronary heart disease: risk assessment and lipid-lowering therapy. J Gen Intern Med (2003) 0.94
Non-invasive evaluation of atherosclerosis with contrast enhanced 16 slice spiral computed tomography: results of ex vivo investigations. Heart (2004) 0.93
Framingham risk prediction equations for incidence of cardiovascular disease using detailed measures for smoking. Heart Int (2010) 0.93
Endothelial dysfunction, intima-media thickness, ankle-brachial pressure index, and pulse pressure in young post-myocardial infarction patients with various expressions of classical risk factors. Heart Vessels (2007) 0.93
Primary prevention of cardiovascular disease using validated risk scores: a systematic review. J R Soc Med (2012) 0.92
Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDIT. Clin Res Cardiol (2007) 0.92
Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 years excess risk in individuals with familial hypercholesterolemia. BMC Public Health (2006) 0.92
Unrequested information from routine diagnostic chest CT predicts future cardiovascular events. Eur Radiol (2011) 0.92
Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function. Mayo Clin Proc (2012) 0.91
Turbulent blood flow plays an essential localizing role in the development of atherosclerotic lesions in experimentally induced hypercholesterolaemia in rats. Int J Exp Pathol (2008) 0.91
Scaling up chronic disease prevention interventions in lower- and middle-income countries. Annu Rev Public Health (2013) 0.91
Smoking, alcohol consumption, physical activity, and family history and the risks of acute myocardial infarction and unstable angina pectoris: a prospective cohort study. BMC Cardiovasc Disord (2011) 0.90
Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: a study in patients with first myocardial infarction. Indian Heart J (2014) 0.89
Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study. BMJ Open (2015) 0.88
Time-efficient black blood RCA wall imaging at 3T using improved motion sensitized driven equilibrium (iMSDE): feasibility and reproducibility. PLoS One (2011) 0.88
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA). BMC Public Health (2010) 0.88
Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons. ScientificWorldJournal (2013) 0.88
Quantification of myocardial perfusion reserve at 1.5 and 3.0 Tesla: a comparison to fractional flow reserve. Int J Cardiovasc Imaging (2012) 0.87
Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer. BMC Public Health (2015) 0.87
Visualization of coronary wall atherosclerosis in asymptomatic subjects and patients with coronary artery disease using magnetic resonance imaging. PLoS One (2010) 0.86
Providing patients with global cardiovascular risk information: is knowledge power? Arch Intern Med (2010) 0.86
Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events. J Nucl Cardiol (2011) 0.86
Diplotyper: diplotype-based association analysis. BMC Med Genomics (2013) 0.85
Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians. Ther Adv Chronic Dis (2011) 0.85
Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J (2003) 3.48
Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks. Int J Epidemiol (2002) 2.48
Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. Eur Heart J (2005) 1.78
Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. Int Microbiol (2004) 1.57
Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol (2008) 1.45
Implications of emerging risk factors for therapeutic intervention. Nutr Metab Cardiovasc Dis (2005) 1.43
PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol. Clin Chem Lab Med (2008) 1.42
Randomised trial of magnesium in the treatment of Irukandji syndrome. Emerg Med Australas (2012) 1.39
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol (2007) 1.38
GTPase-activating proteins for Cdc42. Eukaryot Cell (2002) 1.35
Ten simple rules for doing your best research, according to Hamming. PLoS Comput Biol (2007) 1.32
Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis (2005) 1.30
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet (2006) 1.29
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ Res (2007) 1.27
Response to Conroy et al. SCORE Project. Eur Heart J (2003) 1.20
BLASTing proteomes, yielding phylogenies. In Silico Biol (2003) 1.12
Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol (2007) 1.11
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil (2007) 0.98
Cell surface localization of ABCG1 does not require LXR activation. Arterioscler Thromb Vasc Biol (2006) 0.96
Temperature effects on box jellyfish venom: a possible treatment for envenomed patients? Med J Aust (2002) 0.96
Correspondence of function and phylogeny of ABC proteins based on an automated analysis of 20 model protein data sets. Proteins (2005) 0.93
How to surf today's information tsunami: on the craft of effective reading. Med Hypotheses (2009) 0.93
Characterization of the synthetic compatible solute homoectoine as a potent PCR enhancer. Biochem Biophys Res Commun (2004) 0.92
Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Infect Immun (2005) 0.92
ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett (2004) 0.91
The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women. J Clin Endocrinol Metab (2002) 0.90
The Leptospira interrogans lexA gene is not autoregulated. J Bacteriol (2005) 0.89
Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation). Eur J Cardiovasc Prev Rehabil (2006) 0.88
Endogenous glycosides in critically ill patients. Crit Care Med (2003) 0.88
Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J Nutr (2002) 0.86
Non-LDL-related dyslipidaemia and coronary risk: a case-control study. Diab Vasc Dis Res (2010) 0.86
Cardiovascular risk assessment in metabolic syndrome: view from PROCAM. Endocrinol Metab Clin North Am (2004) 0.84
Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clin Endocrinol (Oxf) (2004) 0.84
VisCoSe: visualization and comparison of consensus sequences. Bioinformatics (2004) 0.84
Cloning, genomic organization, and tissue-specific expression of the RASL11B gene. Biochim Biophys Acta (2007) 0.84
Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model. J Thorac Cardiovasc Surg (2010) 0.83
Severity of Irukandji syndrome and nematocyst identification from skin scrapings. Med J Aust (2003) 0.83
Genes, diet and public health. Genes Nutr (2007) 0.83
The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. Clin Chem (2005) 0.82
Pharmacological regulation of cholesterol efflux in human monocyte-derived macrophages in the absence of exogenous cholesterol acceptors. Atherosclerosis (2005) 0.82
Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening. J Histochem Cytochem (2004) 0.81
Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care. Curr Med Res Opin (2010) 0.80
Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming. Toxicon (2009) 0.79
Relationship between phytosterol levels and components of the metabolic syndrome in the PROCAM study. Eur J Cardiovasc Prev Rehabil (2007) 0.79
The use of pressure immobilization bandages in the first aid management of cubozoan envenomings. Toxicon (2002) 0.78
Cloning, cellular localization, genomic organization, and tissue-specific expression of the TGFbeta1-inducible SMAP-5 gene. Gene (2005) 0.78
Interferences in coagulation tests--evaluation of the 570-nm method on the Dade Behring BCS analyser. Clin Chem Lab Med (2005) 0.78
The multifunctional role of the pallilysin-associated Treponema pallidum protein, Tp0750, in promoting fibrinolysis and extracellular matrix component degradation. Mol Microbiol (2014) 0.78
Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. Clin Cardiol (2008) 0.78
IsoSVM--distinguishing isoforms and paralogs on the protein level. BMC Bioinformatics (2006) 0.77
Evidence for an alternative genomic structure, mRNA and protein sequence of human ABCA13. Gene (2012) 0.76
Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart disease. Nutr Metab Cardiovasc Dis (2006) 0.76
Genetics and molecular biology: apolipoprotein E--from plasma lipids to plaque stability. Curr Opin Lipidol (2002) 0.76
Inflammation in atherosclerosis, not yet time for a paradigm shift? Curr Opin Lipidol (2003) 0.75
Making cars and making health care: a critical review. Med J Aust (2010) 0.75
Comparing Neanderthal and human genomes. Science (2007) 0.75
Results of rush to sequence genomes may be nonsense. Nature (2008) 0.75
"Polypill" to fight cardiovascular disease: interpretation of trial data is optimistic. BMJ (2003) 0.75
Methods to identify increased risk of coronary disease in the general population: conclusion is oversimplification. BMJ (2003) 0.75
Neanderthal, chimp and human genomes: hypotheses wanted for research into brain evolution. Med Hypotheses (2007) 0.75
The evacuation of cairns hospitals due to severe tropical cyclone Yasi. Acad Emerg Med (2012) 0.75
Genetics and molecular biology: peroxisome proliferator-activated receptor gamma still full of surprises. Curr Opin Lipidol (2002) 0.75
[Expression in Escherichia coli of the gspd(l) gene of the type II secretion system in Leptospira borgpetersenii serovariety hardjo]. Rev Cubana Med Trop (2007) 0.75
On the craft of effective lectures. Med Hypotheses (2009) 0.75
High-density lipoprotein cholesterol levels and cholesterol efflux: a missing link? Curr Opin Lipidol (2004) 0.75
Genetics and molecular biology: the ABC of cholesterol efflux and high-density lipoprotein formation. Curr Opin Lipidol (2004) 0.75
Learning new tricks from an old dog: recent findings in familial hypercholesterolemia. Curr Opin Lipidol (2003) 0.75
Complementary thoughts on the future of internet science: Can digital libraries avoid scientific tunnel-vision and lead to innovation? Med Hypotheses (2009) 0.75